SEP 10, 2026 · JOURNAL ARTICLE
Improved quality of life and prolonged survival with add-on homeopathic treatment in patients with non-small cell lung cancer: a prospective, randomized, placebo-controlled, double-blind, three-arm, multicenter study
Supportive Care in Cancer
A phase III RCT with adequate design and sample size reporting survival and QoL benefits for homeopathy, but the original publication was retracted by the journal in November 2025 after corrections, with majority co-author disagreement, creating fundamental uncertainty about the reliability and interpretation of these findings.
Reported
Median survival time: homeopathy…435 days
Median survival time: placebo gro…257 days
Median survival time: control gro…228 days